CHINASOFT INT'L (00354) receives 2 million shares held by major shareholder Chen Yuhong.
China Software International (00354) Announcement: The company received notification from its major shareholder, Chairman and Executive Director Dr. Chen Yuhong on March 27, 2026. Dr. Chen purchased a total of 2 million shares of the company's common stock in the open market on March 27, 2026, at an average price of approximately HK$3.4043 per share, with a total amount of approximately HK$6.8085 million (increase in equity). The total number of common shares acquired through the increase in equity is equivalent to approximately 0.07% of the total number of shares issued by the company as of the date of this announcement. Following the increase in equity, Dr. Chen holds 322 million shares, equivalent to approximately 11.79% of the total number of shares issued by the company as of the date of this announcement.
CHINASOFT INT'L (00354) announced that on March 27, 2026, the company received notification from its major shareholder, Chairman and Executive Director Dr. Chen Yuhong (Dr. Chen) that he had purchased a total of 2 million ordinary shares of the company in the open market on March 27, 2026. The average price per share was approximately HK$3.4043, with a total amount of approximately HK$6.8085 million (increase in equity). The ordinary shares acquired through the increase in equity represent approximately 0.07% of the total number of shares issued by the company as of the date of this announcement. Following the increase in equity, Dr. Chen holds 322 million shares, equivalent to approximately 11.79% of the total number of shares issued by the company as of the date of this announcement.
The Board of Directors believes that the increase in equity reflects Dr. Chen's recognition of the value of the company and his confidence in the overall business development and growth potential of the company in the future.
Related Articles

QUALI-SMART (01348) Increases Public Shareholding

ISDN Holdings (01656) proposes appointing Lin De Cai as an independent non-executive director.

JensCare-B(09877): JensRoboSiasun Robot & Automation assisted TTVR system completes the first clinical study in humans.
QUALI-SMART (01348) Increases Public Shareholding

ISDN Holdings (01656) proposes appointing Lin De Cai as an independent non-executive director.

JensCare-B(09877): JensRoboSiasun Robot & Automation assisted TTVR system completes the first clinical study in humans.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


